Cellular membranes in duchenne muscular dystrophy

International Journal of Biochemistry - Tập 15 - Trang 1211-1217 - 1983
R. Anand1
1University Department of Human Genetics, Western General Hospital. Edinburgh EH4 2XU, U.K. [Tel. 031-332-2471]

Tài liệu tham khảo

Anand, 1980, Calcium stimulated enzyme efflux from human skeletal muscle, Res. Commun. chem. Path. Pharmac., 28, 541 Anand, 1981, Erythrocyte spectrin in Duchcnne muscular dystrophy, Clin. chim. Acta, 117, 345, 10.1016/0009-8981(81)90122-4 Anand, 1982, Verapamil and calcium-stimulated enzyme efflux from skeletal muscle, Clin. Chem., 28, 1482, 10.1093/clinchem/28.7.1482 Bennett, 1979, Identification and partial purification of Ankyrin, the high affinity membrane attachment site for human erythrocyte spectrin, J. biol. Chem., 254, 2533, 10.1016/S0021-9258(17)30254-5 Bodensteiner, 1978, Intracellular calcium accumulation in Duchenne muscular dystropy and other myopathies: a study of 567.000 muscle fibres in 114 biopsies, Neurology, 28, 439, 10.1212/WNL.28.5.439 Brambatie, 1980, Calcium-positive muscle fibres in fetuses at risk for Duchenne muscular dystrophy, Lancet, 2, 969, 10.1016/S0140-6736(80)92121-2 Cullen, 1977, Inclusion bodies in muscular dystrophy, Lancet, 2, 929, 10.1016/S0140-6736(77)90862-5 Das, 1976, Apparent alterations of erythrocyte acetylcholinesterase and other membrane proteins in Duchenne muscular dystrophy: a further example of a generalised membrane defect associated with hereditary muscular dystrophy, Biochem. Soc. Trans, 4, 723, 10.1042/bst0040723 Dise, 1977, Enhanced sensitivity to calcium in Duchenne muscular dystrophy, Biochnn. biophys. Res. Commun., 79, 1286, 10.1016/0006-291X(77)91145-7 Duncan, 1978, Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition, Experientia, 34, 1531, 10.1007/BF02034655 Emery, 1980, Duchenne muscular dystrophy: Genetic aspects, carrier detection and antenatal diagnosis, Brit. Med. Bull., 36, 117, 10.1093/oxfordjournals.bmb.a071624 Emery, 1980, Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy, Br. med. J., 48, 355, 10.1136/bmj.280.6211.355 Emery, 1982, Verapamil in Duchenne muscular dystrophy, Lancet, 1, 559, 10.1016/S0140-6736(82)92063-3 Fairbanks, 1971, Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane, Biochemistry, 10, 2606, 10.1021/bi00789a030 Fisher, 1976, Increased erythrocyte osmotic fragility in pseudohypertrophic muscular dystrophy, J. Am. med. Ass., 236, 955, 10.1001/jama.1976.03270090049032 Grassi, 1978, Deformed erythrocytes in muscular dystrophy, Neurology, 28, 842, 10.1212/WNL.28.8.842 Gratzer, 1981, The red cell membrane and its cytoskeleton, Biochem. J., 198, 1, 10.1042/bj1980001 Harris, 1980, Structural characterisation of the phosphorvlation sites of human erythrocyte spectrin, J. biol. Chem., 255, 11512, 10.1016/S0021-9258(19)70321-4 Hauser, 1979, Lymphocyte capping in Duchenne muscular dystrophy, New Engl. J. Med., 300, 861, 10.1056/NEJM197904123001516 Horenstein, 1980, Human lymphocyte capping in Duchenne muscular dystrophy, Neurology, 30, 1330, 10.1212/WNL.30.12.1330 Howland, 1974, Abnormal potassium conductance associated with genetic muscular dystrophy, Nature, Lond., 251, 724, 10.1038/251724a0 Ionasescu, 1982, Collagen synthesis by Duchenne myogenic clones: Pathogenic implications for the disease, Am. J. med. Genet., 11, 361, 10.1002/ajmg.1320110314 Jones, 1982, A new in vitro technique for the study of factors influencing enzyme and metabolite efflux from skeletal muscle Kirkpatrick, 1975, A23187 and red cells: changes in deformability. K+ Mg2+ Ca2+ and ATP, Experientia, 31, 653, 10.1007/BF01944610 Kobayashi, 1978, Lipids and proteins of erythrocyte membrane in Duchenne muscular dystrophy, Clin. chim. Acta, 85, 259, 10.1016/0009-8981(78)90303-0 Langer, 1975, Localisation of contractile-dependent Ca: comparison of Mn and vcrapamil in cardiac and skeletal muscle, Am. J. Physiol., 229, 1003, 10.1152/ajplegacy.1975.229.4.1003 Leoyd, 1978, Osmotic fragility of erythrocytes in Duchenne muscular dystrophy, Br. med. J., 2, 252, 10.1136/bmj.2.6132.252 LuMii, 1975, Erythrocyte deformation in Duchenne muscular dystrophy, Br. med. J., 3, 467, 10.1136/bmj.3.5981.467-a Lux, 1979, Spectrin-Actin membrane skeleton of normal and abnormal red blood cells, Semin. Hemat., 16, 21 Lux, 1977, Evidence that spectrin is a determinant of shape and deformability of human erythrocyte, Prog. Clin. Biol. Res., 17, 481 Marchesi, 1979, Functional proteins of the human red blood cell membrane, Semin. Hemat., 16, 3 Mclaughein, 1979, Lipid composition of erythrocytes. Findings in Duchenne muscular dystrophy and myotonic atrophy, Archs Neural., 36, 351, 10.1001/archneur.1979.00500420061007 Nonaka, 1980, Muscle pathology in Duchenne dystrophy with particular reference to 'opaque fibres', Adv. neural. Sci., Japan, 24, 718 Oberc, 1977, Ultrastructural localisation of calcium in normal and abnormal skeletal muscle, Lab. Invest., 36, 566 Percy, 1975, Reduced deformability of erythrocyte membrane from patients with Duchenne muscular dvstrophy, Nature. Lond., 258, 147, 10.1038/258147a0 Pickard, 1978, Systemic membrane defect in the proximal muscular dystrophies, New Engt J. Med., 299, 841, 10.1056/NEJM197810192991601 Plishker, 1980, Red blood cell alterations in muscular dystrophy: The role of lipids, Muscle Nerve, 3, 70, 10.1002/mus.880030108 Rosenmann, 1982, Analysis of fibroblast protein from patients with Duchenne muscular dystrophy by two-dimensional gel electrophoresis, Nature. Lond., 298, 563, 10.1038/298563a0 Roses, 1979, More on phosphorylation of red-cell membranes in muscular dystrophy, New Engl. J. Med., 300, 1114, 10.1056/NEJM197905103001916 Roses, 1976, Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy, J. neurol. Sci., 29, 185, 10.1016/0022-510X(76)90170-2 Roses, 1980, Red blood cell and fibroblast membranes in Duehenne and myotonic muscular dystrophy, Muscle Nerve, 3, 36, 10.1002/mus.880030106 Rowland, 1980, Biochemistry of muscle membranes in Duchenne muscular dystrophy, Muscle Nerve, 3, 3, 10.1002/mus.880030103 Schapira, 1953, L'elévation du taux de l'aldolase sérique: test biochemique de myopathies, Sem. Hop. Paris, 29, 1917 Schreiner, 1976, Calcium-sensitive modulation of Ig- capping: evidence supporting a cytoplasmic control of ligand-receptor complexes, J. expl Med., 143, 15, 10.1084/jem.143.1.15 Singh, 1978, Verapamil: A review of its pharmacological properties and therapeutic use, Drugs, 15, 169, 10.2165/00003495-197815030-00001 Soybel, 1978, Calcium augmentation of enzyme leakage from mouse skeletal muscle and its possible site of action. Res, Commun. chem. Path. Pharmac., 20, 317 Stern, 1979, Lymphocyte capping in Duchenne muscular dystrophy, Lancet, 1, 1300, 10.1016/S0140-6736(79)92264-5 Wilkerson, 1978, Erythrocyte membrane abnormalities in DMD monitored by saturation transfer electron paramagnetic resonance spectroscopy, 75, 838 Woodcock, 1980, Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy, J. cardiovas. Pharmac., 2, 17, 10.1097/00005344-198001000-00003 Wyatt, 1977, Duchenne's muscular dystrophy: studies in cultured fibroblasts, Lancet, 1, 172, 10.1016/S0140-6736(77)91768-8